Extensive review fills the gaps on immune system cancer research
New light has been shone on the role of specific protein components of the immune system in both causing and preventing cancer.
May 9, 2022
0
21
New light has been shone on the role of specific protein components of the immune system in both causing and preventing cancer.
May 9, 2022
0
21
The hormone receptor guanylyl cyclase C (GCC) has been established as a suppressor of colorectal cancer tumors, but new evidence from Thomas Jefferson University suggests it may also help fight one of the country's biggest ...
Aug 25, 2011
0
0
A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.
Apr 19, 2013
0
0
An unexpected discovery of how the body controls cell death has revealed a potential new therapeutic target.
Jun 14, 2012
0
0
Some of the greatest insights into cancer and how to treat it come when basic scientists and cancer biologists and clinicians collaborate.
Oct 17, 2019
0
48
Vaccines that save lives by preventing disease have been around for centuries. Now, new vaccines that treat cancer are being developed, but how they will be combined with existing treatments is not clear.
Jun 8, 2011
0
0
A team of researchers from Singapore has discovered a class of small RNA molecules, known as oncomiRs, which are responsible for fuelling lung cancer. Published in Nature Communications, the findings provide fresh insight ...
Jul 12, 2016
0
14
Amplification of anaplastic lymphoma kinase, which has been reported in other cancers such as non-small cell lung cancers, may be a primary driver of the rapid metastasis that patients with inflammatory breast cancer experience.
Nov 13, 2011
0
0
(Medical Xpress)—Imagine that a police bomb squad comes upon a diabolically designed bomb controlled by a tangled mass of different wires, lights and switches, some of which have a real function while others are decoys. ...
Aug 30, 2012
1
0
Glioblastoma multiforme (GBM) is the most common malignant brain cancer in humans. Patients with GBM have a poor prognosis because it is a highly aggressive form of cancer that is commonly resistant to current therapies. ...
Nov 14, 2011
0
0